Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China · Delayed Price · Currency is CNY 11.87
+0.07 (0.59%)
Jul 30, 2026, 12:14 PM CST
SHE:002900 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 813.23 | 789.42 | 1,132 | 1,187 | 1,028 | 945.8 |
Revenue Growth | -25.44% | -30.29% | -4.58% | 15.40% | 8.73% | -29.36% |
Gross Profit Gross Profit Growth | 262.92 | 258.65 | 578.6 | 711.23 | 668.08 | 632.94 |
Operating Income Operating Income Growth | -326.79 | -328.29 | 32.72 | -7.97 | -31.91 | -150.03 |
Net Income Net Income Growth | -317.84 | -339.63 | 58.68 | 73.66 | 30.21 | 350.95 |
Earnings Per Share EPS Growth | -0.98 | -1.07 | 0.19 | 0.24 | 0.10 | 1.13 |
EPS Growth | - | - | -20.83% | 140.00% | -91.15% | 1155.56% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
North-East China North-East China Growth | 290.35 | 520.13 | 465.8 | 304.29 | 287.72 |
East China East China Growth | 175.84 | 167.07 | 190.94 | 214.07 | 230.98 |
Central China Region Central China Region Growth | 78.98 | 96.39 | 102.13 | 87.19 | 66.42 |
Northern China Northern China Growth | 75.98 | 93.1 | 108.38 | 140.5 | 136.11 |
South-West South-West Growth | 56.98 | 76.11 | 110.63 | 124.84 | 97.22 |
Southern China Southern China Growth | 79.61 | 92.28 | 97.24 | 88.35 | 79.57 |
Northwestern Region Northwestern Region Growth | 20.86 | 29.23 | 32.95 | 29.13 | 25.7 |
Overseas Overseas Growth | 10.81 | 58.17 | 78.71 | 40.04 | 22.08 |
Total Total Growth | 789.42 | 1,132 | 1,187 | 1,028 | 945.8 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 488 | 611.64 | 842.15 | 1,049 | 1,294 | 1,112 |
Total Debt Total Debt Growth | 1,029 | 1,119 | 935.63 | 718.38 | 656.73 | 487.67 |
Net Cash (Debt) Net Cash Growth | -541.07 | -507.54 | -93.47 | 330.54 | 637.17 | 623.84 |
Net Cash Growth | - | - | - | -48.12% | 2.14% | -17.09% |
Net Cash Per Share Net Cash Per Share Growth | -1.66 | -1.60 | -0.30 | 1.08 | 2.11 | 2.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -106.34 | -36.25 | 30.69 | 35.69 | 144.64 | -12.53 |
Capital Expenditures CapEx Growth | -202.49 | -247.73 | -346.21 | -299.58 | -89.22 | -73.95 |
Free Cash Flow Free Cash Flow Growth | -308.83 | -283.98 | -315.52 | -263.89 | 55.42 | -86.48 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 32.33% | 32.76% | 51.09% | 59.93% | 64.96% | 66.92% |
Operating Margin | -40.18% | -41.59% | 2.89% | -0.67% | -3.10% | -15.86% |
Pretax Margin | -39.94% | -44.72% | 5.30% | 6.86% | 3.90% | 47.88% |
Profit Margin | -39.08% | -43.02% | 5.18% | 6.21% | 2.94% | 37.11% |
FCF Margin | -37.97% | -35.97% | -27.86% | -22.23% | 5.39% | -9.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.200 | - | 0.200 | 0.200 | 0.100 | 0.320 |
Dividend Per Share Growth | 0% | - | 0% | 100.00% | -68.75% | 300.00% |
Dividend Yield | 1.70% | - | 2.06% | 1.52% | 0.76% | 1.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 51.97 | 57.40 | 139.99 | 18.39 |
Forward PE | - | 40.26 | 40.26 | 40.26 | 40.26 | 40.26 |
P/FCF Ratio | - | - | - | - | 76.30 | - |
PS Ratio | 4.59 | 4.89 | 2.69 | 3.56 | 4.11 | 6.82 |